These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23568543)

  • 1. B-cell lymphoma in a psoriatic patient treated with infliximab.
    Bardazzi F; Antonucci VA; Alessandrini AM; Baraldi C; Tengattini V; Patrizi A
    Eur J Dermatol; 2013 Apr; 23(2):264-5. PubMed ID: 23568543
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adalimumab in arthritis psoriatica].
    Szekanecz Z
    Orv Hetil; 2009 Jul; 150(30):1423. PubMed ID: 19592338
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical inquiries. Are DMARDs effective for rheumatologic diseases besides rheumatoid arthritis?
    Goodemote P; Jamieson B; Hoffman R
    J Fam Pract; 2007 Nov; 56(11):933-4, 937. PubMed ID: 17976342
    [No Abstract]   [Full Text] [Related]  

  • 4. Macrophage activation syndrome revealing disseminated tuberculosis in a patient on infliximab.
    André V; Liddell C; Guimard T; Tanguy G; Cormier G
    Joint Bone Spine; 2013 Jan; 80(1):109-10. PubMed ID: 23286892
    [No Abstract]   [Full Text] [Related]  

  • 5. Osteomyelitis occurring during infliximab treatment of severe psoriasis.
    Sri JC; Tsai CL; Deng A; Gaspari AA
    J Drugs Dermatol; 2007 Feb; 6(2):207-10. PubMed ID: 17373180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab treatment in two patients with psoriatic arthritis and secondary IgA nephropathy.
    Sakellariou GT; Vounotrypidis P; Berberidis C
    Clin Rheumatol; 2007 Jul; 26(7):1132-3. PubMed ID: 16924391
    [No Abstract]   [Full Text] [Related]  

  • 7. [Visceral leishmaniasis related to infliximab administration].
    Romaní-Costa V; Sánchez C; Moyá F; Estany C
    Enferm Infecc Microbiol Clin; 2004 May; 22(5):310. PubMed ID: 15207130
    [No Abstract]   [Full Text] [Related]  

  • 8. Membranous nephropathy with severe tubulointerstitial and vascular changes in a patient with psoriatic arthritis treated with non-steroidal anti-inflammatory drugs.
    Grcevska L; Polenaković M; Ferluga D; Vizjak A; Stavrić G
    Clin Nephrol; 1993 May; 39(5):250-3. PubMed ID: 8513600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adalimumab therapy of psoriasis and psoriatic arthritis in a patient with cirrhosis of the liver.
    Piel S; Dissemond J
    J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S117-8. PubMed ID: 19119119
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential response of psoriatic onycho-pachydermo-periostitis to 2 anti-tumor necrosis factor-alpha agents.
    Kapusta MA; Dumont C
    J Rheumatol; 2008 Oct; 35(10):2077-80. PubMed ID: 18843767
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of different outcome measures for psoriatic arthritis in patients treated with infliximab or placebo.
    Vander Cruyssen B; De Keyser F; Kruithof E; Mielants H; Van den Bosch F
    Ann Rheum Dis; 2007 Jan; 66(1):138-40. PubMed ID: 17178763
    [No Abstract]   [Full Text] [Related]  

  • 12. Psoriatic arthritis in a military aviator.
    Sulit DJ; Clarke JE
    Aviat Space Environ Med; 2005 Jul; 76(7):684-8. PubMed ID: 16018354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healing of psoriatic skin lesions, and improvement of psoriatic arthritis resistant to immunosuppressive drugs, after infliximab treatment.
    Nikas SN; Voulgari PV; Takalou IP; Katsimbri P; Drosos AA
    Ann Rheum Dis; 2005 Nov; 64(11):1665-7. PubMed ID: 16227426
    [No Abstract]   [Full Text] [Related]  

  • 14. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
    Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J
    Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma in a psoriatic arthritis patient treated with infliximab.
    Ursini F; Naty S; Mazzei V; Spagnolo F; Grembiale RD
    Int Immunopharmacol; 2010 Jul; 10(7):827-8. PubMed ID: 20433950
    [No Abstract]   [Full Text] [Related]  

  • 16. Long term treatment of psoriatic arthritis with infliximab.
    Yazdani-Biuki B; Wohlfahrt K; Mulabecirovic A; Mueller T; Hermann J; Graninger WB; Brezinschek HP; Brezinschek RI
    Ann Rheum Dis; 2004 Nov; 63(11):1531-2; author reply 1532. PubMed ID: 15479917
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of severe psoriatic arthritis with infliximab in an 11-year-old child suffering from linear psoriasis along lines of Blaschko.
    Rott S; Küster RM; Mrowietz U
    Br J Dermatol; 2007 Jul; 157(1):191-2. PubMed ID: 17578445
    [No Abstract]   [Full Text] [Related]  

  • 18. Sustained clinical response in psoriatic arthritis patients treated with anti-TNF agents: a 5-year open-label observational cohort study.
    Saougou I; Markatseli TE; Papagoras C; Voulgari PV; Alamanos Y; Drosos AA
    Semin Arthritis Rheum; 2011 Apr; 40(5):398-406. PubMed ID: 20843542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriatic arthritis patients doing better on infliximab than etanercept.
    Smith N; Gadsby K; Deighton C
    Rheumatology (Oxford); 2007 Apr; 46(4):721-2. PubMed ID: 17314216
    [No Abstract]   [Full Text] [Related]  

  • 20. Infliximab in refractory psoriatic arthritis with severe psoriasis: a 2-year experience.
    Voulgari PV; Venetsanopoulou AI; Epagelis EK; Alamanos Y; Takalou I; Drosos AA
    Ann Rheum Dis; 2007 Feb; 66(2):270-1. PubMed ID: 17068063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.